Unraveling the Microbiome’s Complex Role in Immunotherapy


A growing body of evidence has shown that the microbiome influences both the development of disease and patient response to therapy. In the field of immuno- oncology, new insights are coming to the forefront regarding the microbiome’s effect on tumor growth and targeted therapeutics, including immunotherapies such as checkpoint inhibitors.

View PDF